News Zhejiang Orient Gene Biotech Co.,Ltd

Equities

688298

CNE100003RM8

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-06-06 pm EDT			5-day change	1st Jan Change
27.42 ^CNY	-0.18%		-6.48%	-23.32%

May. 16	Orient Gene Biotech's US Unit Gets FDA Clearance for Fentanyl Detectors	MT
Apr. 29	Zhejiang Orient Gene Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Orient Gene Biotech's US Unit Gets FDA Clearance for Fentanyl Detectors	May. 16	MT
Zhejiang Orient Gene Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Zhejiang Orient Gene Biotech's Unit Gets US FDA's Nod to Register Two Products	Apr. 23	MT
Zhejiang Orient Gene Biotech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Zhejiang Orient Gene Biotech Co.,Ltd announces an Equity Buyback for CNY 100 million worth of its shares.	Feb. 07	CI
Zhejiang Orient Gene Biotech Co.,Ltd authorizes a Buyback Plan.	Feb. 06	CI
Zhejiang Orient Gene Obtains Veterinary GMP Certificate, Production License	Jan. 08	MT
Zhejiang Orient Gene Biotech Co.,Ltd(SHSE:688298) dropped from Shanghai Stock Exchange Health Care Sector Index	Dec. 08	CI
Zhejiang Orient Gene Biotech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Orient Gene Biotech Registers New In Vitro Diagnostic Reagents	23-07-13	MT
Zhejiang Orient Gene Biotech Elects Chairman, Vice Chairman	23-06-01	MT
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Zhejiang Orient Gene Registers Two Medical Devices in EU, US	23-03-24	MT
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
IN BRIEF: Omega Diagnostics receives CD4 deferred consideration	22-11-25	AN
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-30	CI
Zhejiang Orient Gene Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Omega Diagnostics Up 16% With Sale Of Loss-Making CD4 Business	22-08-03	MT
ZXBio, Inc. announced that it has received $3.1 million in funding from Zhejiang Orient Gene Biotech Co., Ltd.	22-06-07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Zhejiang Orient Gene Biotech Co.,Ltd

Equities

688298

CNE100003RM8

Summary

Filters